Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
research complements the pillars of the institute’s strengths in three areas: 1) neurodevelopment and psychiatric disorders, 2) neurotrauma and brain injury, and 3) neurodegeneration and aging. Rank and
-
or expression, national origin, marital status, ancestry, present or past history of mental disorder, learning disability or physical disability, political belief, veteran status, sexual orientation, genetic
-
not discriminate on the basis of race, color, religious creed, age, gender, gender identity or expression, national origin, marital status, ancestry, present or past history of mental disorder, learning
-
focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's white matter. The network aims to strengthen the full translational pathway from disease
-
on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's white matter. The network aims to strengthen the full translational pathway, from understanding disease
-
metabolism disorders and maternal diabetes. Furthermore, to date, no specific genetic cause has been identified.(1) The incidence of this malformation remains high, at approximately 1 in 2,000 live births
-
children diagnosed with autism spectrum or related disorders. All behavioral therapy strategies and intervention components will occur through the implementation of a treatment plan that is prepared and
-
Ability to work confidently with PSC clients, clinical psychology faculty and other graduate students Understanding a variety of psychological disorders and mental health systems is desired Bowling Green
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
POSITIONS WITH AN ESTIMATED DURATION OF 2 YEARS. Our research lab is developing small molecule and gene therapies for Angelman syndrome, Pitt-Hopkins syndrome, Dup15q syndrome, and other single gene disorders
-
The University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 2 months ago
of treatment for children and adults with MPS, a group of ultra rare genetic disorders, including clinical trials to test new forms of intravenous enzyme replacement therapy as well as alternative therapies